Catalyst

Slingshot members are tracking this event:

FDA Lifts Partial Clinical Hold on AstraZeneca's (AZN) Studies of Durvalumab

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
AZN

100%
Slingshot Insights Explained
Catalyst Date
Occurred on:
Nov 22, 2016
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Phase 3, Kestrel, Eagle, Partial Clinical Hold, Lifted